Fong-fu Hsu is a Research Professor of Medicine at the Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA. He received his BS in Chemistry from the National Taiwan Normal University, Taipei, Taiwan in 1971, his MS in Chemistry from the National Tsing-Hua University, Hsing-Chu, Taiwan in 1975, and his Ph.D. in Medicinal Chemistry from the University of Utah in 1986. His work has been focused on structural characterization and quantification of complex lipids using tandem mass spectrometry (MS/MS). To carry out the analyses, the state-of-art mass spectrometers, including electrospray ionization (ESI), coupled with tandem quadrupole and ion-trap mass spectrometry, matrix-assisted time-of-flight (MALDI) mass spectrometry, and EI/CI GC/MS, currently equipped in the mass spectrometry facility in lipid research center were used. He has developed various tandem mass spectrometric methods to characterize complex lipids, including steroids, phospholipids, sphingolipids, and glycolipids. Another aspect of his work focuses on the structural characterization of candidates of biological relevance.
Dr. Feng earned her Ph.D. in Pharmaceutical Chemistry from the University of Kansas, where her research focused on drug discovery for parasitic infectious diseases, DMPK, and drug delivery. She further expanded her expertise during her postdoctoral work, specializing in the physical characterization of small molecules and peptides. She has also worked in R&D at Eli Lilly and AbbVie, where she gained experience in developing and validating LC-MS/MS quantitative methods and addressing complex analytical challenges.
Dr. Michael Zhuo Wang is a Professor at the Department of Pharmaceutical Chemistry, School of Pharmacy, The University of Kansas, Lawrence, KS, USA. He received his B.S. degree in Chemistry from Peking University in Beijing, and his Ph.D. in Analytical Chemistry from Duke University. Before joining KU, he became a Research Assistant Professor at the Eshelman School of Pharmacy, the University of North Carolina at Chapel Hill, and completed his postdoctoral research there as well. He is a Consortium for
Parasitic Drug Development (CPDD) member. He teaches Introduction to Clinical Chemistry for PharmD and Pharmaceutical Analysis for PhD. His research projects focus on elucidating drug-drug interaction mechanisms, drug discovery and development for neglected diseases, and pharmaceutical analysis.
